IVITF - Invictus MD Strategies Corp.
| Previous Close | 0.1057 |
| Open | 0.1000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0967 - 0.1108 |
| 52 Week Range | 0.0930 - 1.1100 |
| Volume | 248,248 |
| Avg. Volume | 106,109 |
| Market Cap | 12.426M |
| Beta (3Y Monthly) | 12.27 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1410 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 2016-11-17 |
| 1y Target Est | N/A |
- GlobeNewswire
INVICTUS PROVIDES UPDATE ON ACREAGE PHARMS LTD. AND AB LABORATORIES INC.
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Marc Ripa, Interim Chief Executive Officer and Chief Operating Officer of Invictus, is pleased to report that the Company’s wholly owned subsidiary Acreage Pharms Ltd. (“Acreage Pharms”) has hired Kris Love as Vice-President of Production effective August 1, 2019. Mr. Love has many years of experience in cannabis production in Canada and already has become an integral asset to the Company’s operation.
- GlobeNewswire
INVICTUS AND AUTHENTIC BRANDS GROUP MUTUALLY AGREE TO TERMINATE LICENSE AGREEMENT
FRA: 8IS2) The Company and ABG-HMX, LLC (“ABG”) have mutually agreed to an early termination of the license agreement dated June 1, 2018 (the “License Agreement”) pursuant to an omnibus settlement and termination agreement (the “Termination Agreement”). The Company continues to focus on increasing shareholder value by providing quality cannabis and oil to meet the demand of sales to the medical and recreational markets.
- GlobeNewswire
INVICTUS CLOSES SALE OF FUTURE HARVEST DEVELOPMENT LTD.
Vancouver, B.C., Oct. 17, 2019 -- Vancouver, BC, October 17, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company.
- Simply Wall St.
Imagine Owning Invictus MD Strategies (CVE:GENE) And Trying To Stomach The 89% Share Price Drop
It's not a secret that every investor will make bad investments, from time to time. But it should be a priority to...
- GlobeNewswire
INVICTUS ANNOUNCES APPOINTMENT OF INTERIM CEO AND ALTERNATE DIRECTOR
Vancouver, B.C., Oct. 08, 2019 -- Vancouver, BC, October 8, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces.
- GlobeNewswire
INVICTUS CLOSES SALE OF 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS
Vancouver, B.C., Sept. 24, 2019 -- Vancouver, BC, September 24, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the.
- GlobeNewswire
INVICTUS ENTERS INTO AGREEMENT TO SELL FUTURE HARVEST DEVELOPMENT LTD.
FRA: 8IS1) announces that, the Company has agreed to sell the 82.5% issued and outstanding shares (the “Future Harvest Shares”) of Future Harvest Development Ltd. (“Future Harvest”) which are held by the Company’s wholly owned subsidiary Prestige Worldwide Holdings Inc. (“Prestige”) to SL 152 Ventures Ltd. (“SL 152”), a company owned by Mr. Byron Sheppard, a Director, President and CEO of Future Harvest, and whose company holds the remaining 17.5% of Future Harvest.
- GlobeNewswire
INVICTUS ANNOUNCES AB LABORATORIES INC. RECEIVES AMENDED LICENSE
FRA: 8IS2) is pleased to announce that AB Laboratories Inc. (“AB Labs”) a company which is a 50% owned subsidiary of Invictus has received their amended license from Health Canada to include the new 40,000 sq. ft. custom built cultivation facility located near Hamilton, Ontario. As previously announced on June 26, 2019, AB Labs’ facility contains ten identical cultivation rooms capable of producing over 65 crops annually on a tightly controlled weekly production schedule. Five rooms have been propagated since receiving the amended license on August 30, 2019. The initial harvest is scheduled for November 1, 2019. The remaining rooms are expected to be propagated at a rate of one room per week over the next five weeks to ensure a reliable continuous production of cannabis for the recreational and medical markets.
- GlobeNewswire
INVICTUS SELLS 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS TO REDUCE OPERATIONAL COSTS AND STREAMLINE ITS OPERATIONS
Vancouver, B.C., Aug. 30, 2019 -- Vancouver, BC, August 30, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces.
- GlobeNewswire
ACREAGE PHARMS LTD. SIGNS NON-BINDING TERM SHEET FOR UP TO $6 MILLION FINANCING FROM TRICHOME FINANCIAL
FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd. ("Acreage"), the Company's wholly-owned subsidiary, has signed a non-binding term sheet (the "Term Sheet") for a secured term loan of up to $6.0 million (the “Loan Amount”) with an interest rate of 10.0% per annum (the “Term Loan”) on drawn amounts with Trichome Financial Corp. ("Trichome Financial"). Invictus has also signed the Term Sheet as a guarantor of the Term Loan. The funds drawn on the Term Loan will be used for the completion of the 90,000 square foot Phase III cultivation facility near Edson, Alberta, including the purchase of automated processing equipment and the development of the EU-GMP facility with the remainder to be used for general working capital purposes for both Acreage and the Company.
- Benzinga
The Week Ahead In Cannabis: Lottery In Ontario, Corporate Updates And Earnings
The next five days will still be full of news surrounding the cannabis space. We have compiled a list of main things that cannabis investors should be keeping an eye on this week. Ontario Lottery And New ...
- GlobeNewswire
ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE
Vancouver, B.C., Aug. 14, 2019 -- Vancouver, BC, August 14, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor.
- GlobeNewswire
GENE SIMMONS ABDICATES ROLE AS CHIEF EVANGELIST OFFICER FOR INVICTUS
Vancouver, B.C., Aug. 12, 2019 -- INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that rock icon and marketing.
- GlobeNewswire
ACREAGE PHARMS LTD. ACHIEVES SUBSTANTIAL COMPLETION OF 90,000 SQUARE FOOT PHASE III FACILITY
Vancouver, Aug. 06, 2019 -- Vancouver, BC, August 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor.
- GlobeNewswire
Invictus announces Annual General Meeting Results
Vancouver, British Columbia, July 25, 2019 -- Vancouver, BC, July 25, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA:.
- GlobeNewswire
Invictus announces Closing of Non-Brokered Private Placement
Vancouver, British Columbia, July 09, 2019 -- Vancouver, BC, July 9, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).
- GlobeNewswire
Invictus announces Non-Brokered Private Placement
Vancouver, British Columbia, July 03, 2019 -- Vancouver, BC, July 3, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).
- GlobeNewswire
INVICTUS ANNOUNCES AB VENTURES INC. UPDATE
FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that AB Ventures Inc. (“AB Ventures”), a company which Invictus is a 25% shareholder, is a late stage applicant to obtain a cultivation license under the Cannabis Act. AB Ventures received the approval to proceed to construction and will submit its evidence package upon completion of such construction.
- GlobeNewswire
INVICTUS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS
FRA: 8IS2) today reported financial results for the first quarter ended April 30, 2019. “We are pleased with the progress on reducing the cost of Invictus’ operations and the increases to date on the income generation capacity of the Company. Continued focus on increasing capacity and cost reduction is paramount in developing a profitable business,” stated Mr. Trevor Dixon, Chief Executive Officer of Invictus.
- GlobeNewswire
INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE
Vancouver, June 26, 2019 -- Vancouver, BC, June 26, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon,.
- GlobeNewswire
Invictus announces Annual General Meeting Date
Vancouver, British Columbia, June 20, 2019 -- Vancouver, BC, June 20, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2).
- GlobeNewswire
UPDATE ON ACREAGE PHARMS LTD.
Vancouver, British Columbia, June 12, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive.
- GlobeNewswire
INVICTUS ANNOUNCES APPOINTMENT TO BOARD
FRA: 8IS2) announced today that Mr. Colin Kinsley has been appointed to the Board of Directors as an independent Director. Mr. Kinsley previously served on the Board of Directors of the Corporation (the “Board”) from December, 2014 to June, 2017. Mr. Trevor Dixon, the Company’s Chief Executive Officer, said, “The Company is very pleased to have Mr. Kinsley join the Board.
- GlobeNewswire
INVICTUS ANNOUNCES EXECUTIVE APPOINTMENT
Vancouver, June 05, 2019 -- Vancouver, BC, June 5, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today.
- GlobeNewswire
INVICTUS ANNOUNCES CHANGES TO BOARD
FRA: 8IS2) announced today that Mr. Richard Lee has been appointed to the Board of Directors as an independent Director. Mr. Aaron Bowden has submitted his resignation as a Director in order to devote more time to his other business interests. Mr. Bowden will continue to serve the Company as an advisor. Mr. Bowden was appointed to the Board of Directors on August 19, 2016 and served as Chair of the Audit Committee.
